Ing Groep Nv Astrazeneca PLC Transaction History

Ing Groep Nv

$17.7 Billion
Q3 2025

A detailed history of Ing Groep Nv transactions in Astrazeneca PLC stock. As of the latest transaction made, Ing Groep Nv holds 3,220 shares of AZN stock, worth $287,868. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,220

Previous 13,412 75.99%

Holding current value

$287,868

Previous $937,000 73.64%

% of portfolio

0.0%

Previous 0.01%

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 06, 2025	SELL	$68.72 - $82.11 $700,394 - $836,865	-10,192 Reduced 75.99%	3,220 $247,000
Q2 2025 Aug 06, 2025	BUY	$64.87 - $75.0 $543,091 - $627,900	8,372 Added 166.11%	13,412 $937,000
Q1 2025 May 09, 2025	BUY	$65.37 - $77.96 $329,464 - $392,918	5,040 New	5,040 $370,000
Q3 2023 Oct 27, 2023	BUY	$64.85 - $71.7 $4.36 Million - $4.82 Million	67,231 Added 1897.57%	70,774 $4.79 Million
Q2 2023 Aug 07, 2023	SELL	$69.91 - $75.81 $59,912 - $64,969	-857 Reduced 19.48%	3,543 $253,000

Q1 2023 May 09, 2023	SELL	$63.15 - $71.6 $3.21 Million - $3.64 Million	-50,801 Reduced 92.03%	4,400 $305,000
Q4 2022 Feb 10, 2023	BUY	$54.21 - $70.44 $511,633 - $664,812	9,438 Added 20.62%	55,201 $3.74 Million
Q3 2022 Nov 14, 2022	BUY	$53.02 - $135.75 $639,050 - $1.64 Million	12,053 Added 35.75%	45,763 $2.51 Million
Q2 2022 Aug 08, 2022	BUY	$59.26 - $71.14 $1.12 Million - $1.34 Million	18,823 Added 126.44%	33,710 $2.23 Million
Q1 2022 May 13, 2022	BUY	$55.72 - $67.12 $829,503 - $999,215	14,887 New	14,887 $988,000

Others Institutions Holding AZN

# of Institutions

1,498

Shares Held

500M

Call Options Held

5.59M

Put Options Held

3.18M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $277B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ing Groep Nv, based on Form 13F filings with the SEC.

News

Stay updated on Ing Groep Nv with notifications on news.

Account